Evidence map›Paper›PMID 28771676›Full record

ArticleBritish journal of haematology2018

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis.

Abraham S Kanate, Alyssa DiGilio, Kwang W Ahn, Monzr Al Malki, Eric Jacobsen, Amir Steinberg, Nelson Hamerschlak, Mohamed Kharfan-Dabaja, Rachel Salit, Edward Ball and 21 more

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell LymphomaTurkish journal of haematology : official journal of Turkish Society of Haematology · 2021
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Molecular pathogenesis and evolving treatment landscape of extranodal NK/T-cell lymphoma.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. How we treat NK/T-cell lymphomas.Journal of hematology & oncology · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 5 countries.

Abraham S KanateOsborn Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, WV, USA.
Alyssa DiGilioCIBMTR (Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Kwang W AhnCIBMTR (Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Monzr Al MalkiCity of Hope National medical Center, Duarte, CA, USA.
Eric JacobsenDana Farber Cancer Institute, Boston, MA, USA.
Amir SteinbergDepartment of Hematology-Oncology, Mount Sinai Hospital, New York, NY, USA.
Nelson HamerschlakAlbert Einstein Hospital, Sao Paulo, Brazil.
Mohamed Kharfan-DabajaDepartment of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.ORCID 0000-0001-7394-5185
Rachel SalitFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Edward BallUniversity of California San Diego Medical Center, La Jolla, CA, USA.
Qaiser BashirDepartment of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Amanda CashenDivision of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Daniel CourielUtah Blood and Marrow Transplant Program, Salt Lake City, UT, USA.
Jose Diez-MartinHospital General Universitario Gregorio Maranon, Madrid, Spain.
Emmanuel KatsanisUniversity of Arizona Medical Center, Tucson, AZ, USA.ORCID 0000-0003-1466-6965
Yulia LinharesSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Shahram MoriBlood & Marrow Transplant Center, Florida Hospital Medical Group, Kissimmee, FL, USA.
Richard NashColorado Blood Cancer Institute, Denver, CO, USA.
Attaphol PawarodeBlood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI, USA.
Miguel-Angel PeralesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Colin D PhippsDepartment of Haematology, Singapore General Hospital, Singapore, Singapore.
Carol RichmanUniversity of California Davis Cancer Center, Sacramento, CA, USA.
Bipin N SavaniDivision of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Michael Y ShapiraDepartment of Bone Marrow Transplant, Hadassah Medical Centre, Jerusalem, Israel.
Patrick StiffLoyola University Medical Center, Maywood, IL, USA.
Roger StrairRobert Wood Johnson University Hospital, New Brunswick, NJ, USA.
Timothy S FenskeRobert Wood Johnson University Hospital, New Brunswick, NJ, USA.
Sonali M SmithSection of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.
Anna SuredaHaematology Department, Institut Català d'Oncologia - Hospitalet, Barcelona, Spain.
Horatiu OlteanuDepartment of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0001-5783-4485
Mehdi HamadaniCIBMTR (Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0001-5372-510X
Medical College of Wisconsin · USRobert Wood Johnson University Hospital · USBanner - University Medical Center Tucson · USCedars-Sinai Medical Center · USCity Of Hope National Medical Center · USColorado Blood Cancer Institute · USDana-Farber Cancer Institute · USFlorida Hospital Medical Group · USFred Hutch Cancer Center · USHadassah Medical Center · ILHospital General Universitario Gregorio Marañón · ESHospital Israelita Albert Einstein · BRInstitut Català d'Oncologia · ESLoyola University Medical Center · USMemorial Sloan Kettering Cancer Center · USMoffitt Cancer Center · USMount Sinai Hospital · USSingapore General Hospital · SGThe University of Texas MD Anderson Cancer Center · USUniversity of California, Davis · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Easy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8M
NCI NIH HHS P30 CA008748NCI NIH HHS U24 CA076518NHLBI NIH HHS U10 HL069294
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedFemaleFollow-Up StudiesHematopoietic Stem Cell TransplantationHumansLymphoma, Extranodal NK-T-CellMaleMiddle AgedNose NeoplasmsRegistriesRetrospective StudiesSalvage TherapySurvival AnalysisTransplantation, HomologousTreatment Outcomeallogeneic haematopoietic cell transplantationextranodal NK/T-cell lymphomanon-relapse mortalityrelapsesurvival

Identifiers

PMID28771676
PMCPMC5796874
OpenAlexW2744089784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.